185 related articles for article (PubMed ID: 17201140)
1. COX-2 inhibitor celecoxib suppresses tumor growth and lung metastasis of a murine mammary cancer.
Yoshinaka R; Shibata MA; Morimoto J; Tanigawa N; Otsuki Y
Anticancer Res; 2006; 26(6B):4245-54. PubMed ID: 17201140
[TBL] [Abstract][Full Text] [Related]
2. Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism.
Shibata MA; Ito Y; Morimoto J; Otsuki Y
Carcinogenesis; 2004 Oct; 25(10):1887-98. PubMed ID: 15180944
[TBL] [Abstract][Full Text] [Related]
3. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
[TBL] [Abstract][Full Text] [Related]
4. Vaticanol C, a novel resveratrol tetramer, reduces lymph node and lung metastases of mouse mammary carcinoma carrying p53 mutation.
Shibata MA; Akao Y; Shibata E; Nozawa Y; Ito T; Mishima S; Morimoto J; Otsuki Y
Cancer Chemother Pharmacol; 2007 Oct; 60(5):681-91. PubMed ID: 17256131
[TBL] [Abstract][Full Text] [Related]
5. Panaxanthone isolated from pericarp of Garcinia mangostana L. suppresses tumor growth and metastasis of a mouse model of mammary cancer.
Doi H; Shibata MA; Shibata E; Morimoto J; Akao Y; Iinuma M; Tanigawa N; Otsuki Y
Anticancer Res; 2009 Jul; 29(7):2485-95. PubMed ID: 19596918
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 inhibitor induces apoptosis in breast cancer cells in an in vivo model of spontaneous metastatic breast cancer.
Basu GD; Pathangey LB; Tinder TL; Lagioia M; Gendler SJ; Mukherjee P
Mol Cancer Res; 2004 Nov; 2(11):632-42. PubMed ID: 15561779
[TBL] [Abstract][Full Text] [Related]
7. The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: an intravital microscopy study in mice.
Klenke FM; Gebhard MM; Ewerbeck V; Abdollahi A; Huber PE; Sckell A
BMC Cancer; 2006 Jan; 6():9. PubMed ID: 16409625
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo effects and mechanisms of celecoxib-induced growth inhibition of human hepatocellular carcinoma cells.
Cui W; Yu CH; Hu KQ
Clin Cancer Res; 2005 Nov; 11(22):8213-21. PubMed ID: 16299255
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
Ferrario A; Fisher AM; Rucker N; Gomer CJ
Cancer Res; 2005 Oct; 65(20):9473-8. PubMed ID: 16230411
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism.
Patel MI; Subbaramaiah K; Du B; Chang M; Yang P; Newman RA; Cordon-Cardo C; Thaler HT; Dannenberg AJ
Clin Cancer Res; 2005 Mar; 11(5):1999-2007. PubMed ID: 15756026
[TBL] [Abstract][Full Text] [Related]
11. Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer.
Kundu N; Fulton AM
Cancer Res; 2002 Apr; 62(8):2343-6. PubMed ID: 11956094
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis of murine lupus T cells induced by the selective cyclooxygenase-2 inhibitor celecoxib: molecular mechanisms and therapeutic potential.
Yang P; Zhang Y; Ping L; Gao XM
Int Immunopharmacol; 2007 Nov; 7(11):1414-21. PubMed ID: 17761345
[TBL] [Abstract][Full Text] [Related]
14. The cyclooxygenase-2 inhibitor, celecoxib, prevents the development of mammary tumors in Her-2/neu mice.
Lanza-Jacoby S; Miller S; Flynn J; Gallatig K; Daskalakis C; Masferrer JL; Zweifel BS; Sembhi H; Russo IH
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1486-91. PubMed ID: 14693742
[TBL] [Abstract][Full Text] [Related]
15. COX-2 inhibitors and genetic background reduce mammary tumorigenesis in cyclooxygenase-2 transgenic mice.
Narko K; Zweifel B; Trifan O; Ristimäki A; Lane TF; Hla T
Prostaglandins Other Lipid Mediat; 2005 May; 76(1-4):86-94. PubMed ID: 15967164
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells.
Qin J; Yuan J; Li L; Liu H; Qin R; Qin W; Chen B; Wang H; Wu K
Biomed Pharmacother; 2009 Mar; 63(3):241-8. PubMed ID: 18617357
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
Liu B; Shi ZL; Feng J; Tao HM
Cell Biol Int; 2008 May; 32(5):494-501. PubMed ID: 18078766
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor.
Liang L; Hu D; Liu W; Williams JP; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S114-21. PubMed ID: 12902868
[TBL] [Abstract][Full Text] [Related]
19. Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells.
Suh YJ; Chada S; McKenzie T; Liu Y; Swisher SG; Lucci A; Hunt KK
Surgery; 2005 Sep; 138(3):422-30. PubMed ID: 16213894
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
Narayanan BA; Narayanan NK; Pttman B; Reddy BS
Prostate; 2006 Feb; 66(3):257-65. PubMed ID: 16175586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
